α2α5β2 nAChR Expression Systems for Robust α5 Trafficking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing recombinant cell lines fail to robustly express the α5 subunit of nicotinic acetylcholine receptors (nAChR), hindering the identification of compounds that modulate α5-containing nAChRs, such as α2α5β2 nAChR, which are crucial for drug discovery targeting nicotine addiction and related disorders.
Innovation Solution
Development of isolated recombinant cells that express α5 subunit of nAChR, utilizing heterologous nucleic acids encoding α5, α2, β2 subunits, chaperone proteins like TMIE and FAM163B, and enzymes SAT1 and CHAT, to enhance functional expression of α2α5β2 nAChR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If typical recombinant cell lines are used for drug discovery, then the cell lines are easy to maintain and operate, but they fail to robustly express the α5 subunit of nAChR, preventing identification of modulating compounds
Solution Approach 1:
The patent divides the complex expression problem into manageable segments by separately optimizing for each nAChR subunit (α2, α5, β2) and introducing them in a coordinated manner. The α5 subunit expression is further segmented by introducing chaperone proteins (TMIE, FAM163B) that specifically assist α5 folding and trafficking, allowing each component to be optimized independently while achieving robust functional expression of the complete α2α5β2 receptor.
Solution Approach 2:
The patent introduces chaperone proteins (TMIE and FAM163B) as intermediary molecules that facilitate the proper folding, assembly, and trafficking of the α5 subunit to the cell surface. These chaperones act as mediators between the α5 subunit and the cellular quality control machinery, enabling robust expression of this previously difficult-to-express subunit in HEK293 cells.
2Reliability
If the α5 subunit is introduced alone into recombinant cells, then the cell line remains simple, but the α5 subunit is not robustly expressed due to improper folding and trafficking
Solution Approach 1:
The patent introduces chaperone proteins (TMIE and FAM163B) as intermediary molecules that facilitate the proper folding, assembly, and trafficking of the α5 subunit to the cell surface. These chaperones act as mediators between the α5 subunit and the cellular quality control machinery, enabling robust expression of this previously difficult-to-express subunit in HEK293 cells.
Solution Approach 2:
The patent optimizes multiple parameters simultaneously: the choice of HEK293 cell line as host, the specific chaperone proteins introduced (TMIE, FAM163B), the stoichiometric ratios of subunit expression, and the culture conditions. By changing these parameters in a coordinated fashion, the patent achieves robust α5 expression without requiring overly complex cell line engineering.
3Reliability
If multiple subunits and chaperone proteins are co-expressed to achieve robust α2α5β2 nAChR expression, then functional expression is achieved, but the system complexity increases
Solution Approach 1:
The patent merges the expression of multiple components (α2, α5, β2 subunits plus TMIE and FAM163B chaperones) into a single coordinated transfection protocol using HEK293 cells. This merging approach allows all necessary components to be introduced simultaneously in optimal ratios, achieving functional α2α5β2 nAChR expression while streamlining the manufacturing process compared to sequential introduction methods.
Solution Approach 2:
The introduced chaperone proteins (TMIE, FAM163B) provide self-service functionality by automatically assisting in the folding, assembly, and quality control of the nAChR subunits once introduced into the cell. This self-service mechanism reduces the need for complex external optimization and allows the cell line to autonomously achieve proper receptor assembly and surface expression.
4Reliability
If α5 subunit is expressed without proper chaperones, then the cell line composition remains simple, but the subunit misfolds and fails to traffic to the cell surface
Solution Approach 1:
The patent introduces chaperone proteins (TMIE and FAM163B) as intermediary molecules that facilitate the proper folding, assembly, and trafficking of the α5 subunit to the cell surface. These chaperones act as mediators between the α5 subunit and the cellular quality control machinery, enabling robust expression of this previously difficult-to-express subunit in HEK293 cells.
Data Source
AI summary
Disclosed herein are isolated recombinant cells for the expression of α2α5β2 nicotinic acetylcholine receptor (nAChR) and methods of use thereof.